Publication | Closed Access

Allogeneic haematopoietic stem cell transplantation improves outcome of adults with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia entering remission following CD19 chimeric antigen receptor T cells

Cell TherapyTransplantationMarrow TransplantationStem Cell TransplantationHematologyImmunologyAutoimmunityCell TransplantationAdult T-cell Leukemia-lymphomaImmunotherapyMedicineRadiation OncologyHealth Sciences